UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 298

Sortiert nach

Lung neuroendocrine neoplasms: recent progress and persistent challenges

Modern pathology, 2022-01, Vol.35 (Suppl 1), p.36-50

Rekhtman, Natasha

2022

Link zum Volltext

Verfügbarkeit prüfen

Neuroendocrine tumors of the lung: an update

Archives of pathology & laboratory medicine (1976), 2010-11, Vol.134 (11), p.1628-1638

Rekhtman, Natasha

2010

Link zum Volltext

Verfügbarkeit prüfen

MET-dependent solid tumours - molecular diagnosis and targeted therapy

Nature reviews. Clinical oncology, 2020-09, Vol.17 (9), p.569-587

2020

Link zum Volltext

Verfügbarkeit prüfen

Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy

The lancet oncology, 2012-10, Vol.13 (10), p.e418-e426

2012

Link zum Volltext

Verfügbarkeit prüfen

The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

Journal of thoracic oncology, 2022-03, Vol.17 (3), p.362-387

2022

Link zum Volltext

Verfügbarkeit prüfen

PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer

Clinical cancer research, 2017-01, Vol.23 (2), p.523-535

2017

Link zum Volltext

Verfügbarkeit prüfen

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

Nature communications, 2022-03, Vol.13 (1), p.1450-1450, Article 1450

2022

Link zum Volltext

Verfügbarkeit prüfen

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

Science (American Association for the Advancement of Science), 2015-04, Vol.348 (6230), p.124-128

2015

Link zum Volltext

Verfügbarkeit prüfen

Cabozantinib in patients with advanced RET -rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

The lancet oncology, 2016-12, Vol.17 (12), p.1653-1660

2016

Link zum Volltext

Verfügbarkeit prüfen

Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma

Modern pathology, 2020-11, Vol.33 (11), p.2244-2255

2020

Link zum Volltext

Verfügbarkeit prüfen

A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

Journal of thoracic oncology, 2020-10, Vol.15 (10), p.1599-1610

2020

Link zum Volltext

Verfügbarkeit prüfen

p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma

Modern pathology, 2012-03, Vol.25 (3), p.405-415

2012

Link zum Volltext

Verfügbarkeit prüfen

EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics

Molecular cancer therapeutics, 2013-02, Vol.12 (2), p.220-229

2013

Link zum Volltext

Verfügbarkeit prüfen

Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets

Clinical cancer research, 2016-07, Vol.22 (14), p.3618-3629

2016

Link zum Volltext

Verfügbarkeit prüfen

The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

Journal of thoracic oncology, 2020-09, Vol.15 (9), p.1409-1424

2020

Link zum Volltext

Verfügbarkeit prüfen

SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas

Journal of thoracic oncology, 2020-02, Vol.15 (2), p.231-247

2020

Link zum Volltext

Verfügbarkeit prüfen

Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts

Nature communications, 2022-04, Vol.13 (1), p.2144-2144, Article 2144

2022

Link zum Volltext

Verfügbarkeit prüfen

Spread through Air Spaces (STAS) Is an Independent Predictor of Recurrence and Lung Cancer–Specific Death in Squamous Cell Carcinoma

Journal of thoracic oncology, 2017-02, Vol.12 (2), p.223-234

2017

Link zum Volltext

Verfügbarkeit prüfen

Quick Reference Handbook for Surgical Pathologists

2nd ed. 2019., 2019

Link zum Volltext

Verfügbarkeit prüfen

Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations

Clinical cancer research, 2012-02, Vol.18 (4), p.1167-1176

2012

Link zum Volltext

Verfügbarkeit prüfen

Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer

Nature communications, 2021-08, Vol.12 (1), p.4789-19, Article 4789

2021

Link zum Volltext

Verfügbarkeit prüfen

Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer

Cell reports (Cambridge), 2020-12, Vol.33 (9), p.108444-108444, Article 108444

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 298

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(289)

Publikationsform

Artikel
(251)
Buchkapitel
(44)
Bücher
(2)
Berichte
(1)

Sprache

Englisch
(297)
Japanisch
(64)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Lung neuroendocrine neoplasms: recent progress and persistent challenges

Neuroendocrine tumors of the lung: an update

MET-dependent solid tumours - molecular diagnosis and targeted therapy

Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy

The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

Cabozantinib in patients with advanced RET -rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma

A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics

Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets

The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer

SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas

Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts

Spread through Air Spaces (STAS) Is an Independent Predictor of Recurrence and Lung Cancer–Specific Death in Squamous Cell Carcinoma

Quick Reference Handbook for Surgical Pathologists

Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies

Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations

Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer

Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer

Suchergebnisse filtern